2 ms·
This Rockefeller University study is about blood/serum antibodies. It would be good to compare with the efficacy of nasal/mucosal antibodies in individuals who
by walterbell 5y ago
This Rockefeller University study is about blood/serum antibodies. It would be good to compare with the efficacy of nasal/mucosal antibodies in individuals who recovered from Covid infection, which could stop infection in the upper respiratory tract before reaching blood.
- tomrod 5y agoDo they typically differ?
- walterbell 5y agoFrom a recent BBC article on immunity, https://www.bbc.com/news/health-58270098 https://www.bbc.com/news/health-58270098 > There is a whole different suite of antibodies (known as immunoglobulin As) in the nose and lungs, compared with those (immunoglobulin Gs) that we measure in the blood. The former is more important as a barrier to infection. Natural infection, because it is in the nose rather than a jab in the arm, may be a better route to those antibodies, and nasal vaccines are being investigated too. Existing vaccines prioritize reducing the risk of illness after infection, rather than stopping infection in the first place. CDC updated their vaccine definition in Sept. 2021, to make this distinction clearer.